Israel Biotech Fund II, L.P.
Insider CIK 1782947 · ADXS Director, 10% owner
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| ADXS Ayala Pharmaceuticals, Inc | M Exercise deriv | 2024-03-01 | 2024-03-06 | 1,500,000 | — | $0 | 5,587,500 | SEC↗ |
| ADXS Ayala Pharmaceuticals, Inc | M Exercise deriv | 2024-03-01 | 2024-03-06 | 2,250,000 | — | $0 | 7,837,500 | SEC↗ |
| ADXS Ayala Pharmaceuticals, Inc | M Exercise deriv | 2024-03-01 | 2024-03-06 | 1,500,000 | — | $0 | 11,212,500 | SEC↗ |
| ADXS Ayala Pharmaceuticals, Inc | M Exercise deriv | 2024-03-01 | 2024-03-06 | 2,250,000 | — | $0 | 13,462,500 | SEC↗ |
| ADXS Ayala Pharmaceuticals, Inc | M Exercise deriv | 2024-03-01 | 2024-03-06 | 3,750,000 | — | $0 | 9,712,500 | SEC↗ |
| ADXS Ayala Pharmaceuticals, Inc | M Exercise deriv | 2024-03-01 | 2024-03-06 | 3,750,000 | — | $0 | 4,087,500 | SEC↗ |
| ADXS Ayala Pharmaceuticals, Inc | M Exercise deriv | 2024-02-07 | 2024-02-12 | 4,237,687 | — | $0 | 18,996,000 | SEC↗ |
| ADXS Ayala Pharmaceuticals, Inc | M Exercise deriv | 2024-02-07 | 2024-02-12 | 1,926,221 | — | $0 | 13,661,159 | SEC↗ |
| ADXS Ayala Pharmaceuticals, Inc | M Exercise deriv | 2024-02-07 | 2024-02-12 | 8,437,500 | — | $0 | 7,837,500 | SEC↗ |
| ADXS Ayala Pharmaceuticals, Inc | M Exercise deriv | 2024-02-07 | 2024-02-12 | 1,295,813 | — | $0 | 14,758,313 | SEC↗ |
| ADXS Ayala Pharmaceuticals, Inc | M Exercise deriv | 2024-02-07 | 2024-02-12 | 8,062,500 | — | $0 | 13,462,500 | SEC↗ |
| ADXS Ayala Pharmaceuticals, Inc | M Exercise deriv | 2024-02-07 | 2024-02-12 | 3,887,438 | — | $0 | 11,724,938 | SEC↗ |
| ADXS Ayala Pharmaceuticals, Inc | M Exercise | 2024-02-07 | 2024-02-12 | 1,295,813 | $0.40 | $518.3K | 19,655,308 | SEC↗ |
| ADXS Ayala Pharmaceuticals, Inc | M Exercise | 2024-02-07 | 2024-02-12 | 8,062,500 | $0.40 | $3.23M | 27,717,808 | SEC↗ |
| ADXS Ayala Pharmaceuticals, Inc | F Tax w/h | 2024-02-07 | 2024-02-12 | 2,707,581 | $1.25 | $3.38M | 20,661,639 | SEC↗ |
| ADXS Ayala Pharmaceuticals, Inc | M Exercise | 2024-02-07 | 2024-02-12 | 8,437,500 | $0.40 | $3.38M | 23,369,220 | SEC↗ |
| ADXS Ayala Pharmaceuticals, Inc | F Tax w/h | 2024-02-07 | 2024-02-12 | 2,586,905 | $1.25 | $3.23M | 25,130,903 | SEC↗ |
| ADXS Ayala Pharmaceuticals, Inc | M Exercise | 2024-02-07 | 2024-02-12 | 3,887,438 | $0.40 | $1.55M | 14,931,720 | SEC↗ |
| ADXS Ayala Pharmaceuticals, Inc | M Exercise | 2024-02-07 | 2024-02-12 | 4,237,687 | $0.40 | $1.70M | 18,359,495 | SEC↗ |
| ADXS Ayala Pharmaceuticals, Inc | M Exercise | 2024-02-07 | 2024-02-12 | 1,926,221 | $0.40 | $770.5K | 11,044,282 | SEC↗ |
| ADXS Ayala Pharmaceuticals, Inc | P Buy deriv | 2023-11-17 | 2023-11-21 | 10,312,500 | — | $0 | 17,246,808 | SEC↗ |
| ADXS Ayala Pharmaceuticals, Inc | P Buy deriv | 2023-11-17 | 2023-11-21 | 6,187,500 | — | $0 | 12,221,808 | SEC↗ |
| ADXS Ayala Pharmaceuticals, Inc | P Buy deriv | 2023-11-17 | 2023-11-21 | 6,187,500 | — | $0 | 6,034,308 | SEC↗ |
| ADXS Ayala Pharmaceuticals, Inc | P Buy deriv | 2023-11-17 | 2023-11-21 | 2,812,500 | — | $0 | 6,905,561 | SEC↗ |
| ADXS Ayala Pharmaceuticals, Inc | P Buy deriv | 2023-11-17 | 2023-11-21 | 0 | — | $0 | 27,559,308 | SEC↗ |
| ADXS Ayala Pharmaceuticals, Inc | P Buy deriv | 2023-11-17 | 2023-11-21 | 0 | — | $0 | 23,180,561 | SEC↗ |
| ADXS Ayala Pharmaceuticals, Inc | P Buy deriv | 2023-11-17 | 2023-11-21 | 5,625,000 | — | $0 | 9,718,061 | SEC↗ |
| ADXS Ayala Pharmaceuticals, Inc | P Buy deriv | 2023-11-17 | 2023-11-21 | 4,687,500 | — | $0 | 18,493,061 | SEC↗ |
| ADXS Ayala Pharmaceuticals, Inc | P Buy deriv | 2023-11-17 | 2023-11-21 | 3,150,000 | — | $0 | 14,096,808 | SEC↗ |
| ADXS Ayala Pharmaceuticals, Inc | P Buy deriv | 2023-11-17 | 2023-11-21 | 3,150,000 | — | $0 | 15,343,061 | SEC↗ |
| ADXS Ayala Pharmaceuticals, Inc | P Buy | 2023-10-18 | 2023-10-31 | 658,858 | — | $0 | 2,584,909 | SEC↗ |
| ADXS Ayala Pharmaceuticals, Inc | P Buy | 2023-10-18 | 2023-10-31 | 658,858 | — | $0 | 1,094,091 | SEC↗ |
| ADXS Ayala Pharmaceuticals, Inc | P Buy deriv | 2023-09-01 | 2023-09-11 | 0 | $500000.00 | $0 | 434,783 | SEC↗ |
| ADXS Ayala Pharmaceuticals, Inc | P Buy deriv | 2023-09-01 | 2023-09-11 | 0 | $1500000.00 | $0 | 1,304,348 | SEC↗ |
| ADXS Ayala Pharmaceuticals, Inc | P Buy deriv | 2023-09-01 | 2023-09-29 | 0 | $1500000.00 | $0 | 1,304,348 | SEC↗ |
| ADXS Ayala Pharmaceuticals, Inc | P Buy deriv | 2023-09-01 | 2023-09-29 | 0 | $500000.00 | $0 | 434,783 | SEC↗ |